Drug application
DIASTAT (DIAZEPAM)
Drugs@FDA NDA 020648 · BAUSCH
Key facts
| Drug name | DIASTAT |
|---|---|
| Active ingredients | DIAZEPAM |
| Application type | NDA |
| Application number | 020648 |
| Company | BAUSCH |
| Dosage forms | GEL, RECTAL |
| Strength | 2.5MG/0.5ML (5MG/ML) |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | Yes |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Jul 29, 1997 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- No FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: